Sangamo Therapeutics' recent press release covered ... As a result, I plan on remaining nimble and will look to trade small lots between my Buy Threshold of $1.00 per share and my Sell Target ...

AbbVie agrees a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will add an oral peptide for psoriasis to its pipeline. Join the conversation, on Tuesday 28th January ...

AbbVie agrees a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will add an oral peptide for psoriasis to its pipeline. Join the conversation, on Tuesday 28th January ...

Mazda is determined to provide a crossover SUV to please every category of buyer. Sliding in between the CX-50 and CX-90 is the all new CX-70. Offering two rows of seating (versus the three rows ...

We recently compiled a list of the 12 Best Multibagger Stocks to Buy Right Now. In this article, we are going to take a look ...

BARDA tapped a team of Fred Hutch Cancer Center biostatisticians to determine the biomarkers that will serve as predictors of ...

Analyst Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Neumora Therapeutics, Inc. (NMRA – Research Report) and keeping the price target at $30.00. Discover the latest stocks ...

Maxim Group analyst Jason McCarthy maintained a Buy rating on Capricor Therapeutics (CAPR – Research Report) yesterday and set a price target of $25.00. Discover the latest stocks recommended by ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Piper Sandler analyst David Amsellem maintained an Overweight rating and cut the price ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $39.36, denoting a +1.84% change from the preceding trading day. We recently compiled a list of the Top 11 CRISPR ...